Tanaka KA - Search Results

1

Management of Patients With Hemophilia Undergoing Cardiac Surgery.

Bolliger D, Vandyck K, Tanaka KA. Bolliger D, et al. Among authors: tanaka ka. J Cardiothorac Vasc Anesth. 2022 Feb;36(2):539-541. doi: 10.1053/j.jvca.2021.11.022. Epub 2021 Nov 19. J Cardiothorac Vasc Anesth. 2022. PMID: 34933808 No abstract available.

2

Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery?

Bolliger D, Gonsahn M, Levy JH, Williams WH, Tanaka KA. Bolliger D, et al. Among authors: tanaka ka. Transfusion. 2009 Sep;49(9):2006-7; author reply 2007-8. doi: 10.1111/j.1537-2995.2009.02295.x. Transfusion. 2009. PMID: 19735504 No abstract available.

3

In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma.

Rumph B, Bolliger D, Narang N, Molinaro RJ, Levy JH, Szlam F, Tanaka KA. Rumph B, et al. Among authors: tanaka ka. J Cardiothorac Vasc Anesth. 2010 Jun;24(3):408-12. doi: 10.1053/j.jvca.2009.07.012. Epub 2009 Oct 12. J Cardiothorac Vasc Anesth. 2010. PMID: 19819728

4

Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry.

Bolliger D, Seeberger MD, Tanaka KA, Dell-Kuster S, Gregor M, Zenklusen U, Grapow M, Tsakiris DA, Filipovic M. Bolliger D, et al. Among authors: tanaka ka. Platelets. 2009 Nov;20(7):458-65. doi: 10.3109/09537100903236462. Platelets. 2009. PMID: 19852683 Free article.

5

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.

Bolliger D, Sreeram G, Duncan A, Molinaro RJ, Szlam F, Chen EP, Tanaka KA. Bolliger D, et al. Among authors: tanaka ka. Ann Thorac Surg. 2009 Nov;88(5):1666-8. doi: 10.1016/j.athoracsur.2009.03.095. Ann Thorac Surg. 2009. PMID: 19853132

6

Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin.

Szlam F, Luan D, Bolliger D, Szlam AD, Levy JH, Varner JD, Tanaka KA. Szlam F, et al. Among authors: tanaka ka. Thromb Res. 2010 May;125(5):432-7. doi: 10.1016/j.thromres.2009.11.018. Epub 2009 Dec 11. Thromb Res. 2010. PMID: 20004955

7

Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.

Ide M, Bolliger D, Taketomi T, Tanaka KA. Ide M, et al. Among authors: tanaka ka. J Anesth. 2010 Feb;24(1):96-106. doi: 10.1007/s00540-009-0866-9. Epub 2009 Dec 29. J Anesth. 2010. PMID: 20039075 Review.

8

In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition.

Szlam F, Tanaka KA, Rumph B, Bolliger D, Levy JH. Szlam F, et al. Among authors: tanaka ka. Thromb Haemost. 2010 Apr;103(4):863-5. doi: 10.1160/TH09-09-0632. Epub 2010 Feb 2. Thromb Haemost. 2010. PMID: 20135070 No abstract available.

9

Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice.

Bolliger D, Szlam F, Suzuki N, Matsushita T, Tanaka KA. Bolliger D, et al. Among authors: tanaka ka. Thromb Haemost. 2010 Jun;103(6):1233-8. doi: 10.1160/TH09-10-0732. Epub 2010 Mar 29. Thromb Haemost. 2010. PMID: 20352163

10

Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.

Sniecinski RM, Chen EP, Makadia SS, Kikura M, Bolliger D, Tanaka KA. Sniecinski RM, et al. Among authors: tanaka ka. J Cardiothorac Vasc Anesth. 2010 Dec;24(6):959-63. doi: 10.1053/j.jvca.2010.02.018. Epub 2010 Apr 28. J Cardiothorac Vasc Anesth. 2010. PMID: 20430647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters